Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
Cardinal Health logo

Cardinal Health Cash Flow Statement

Operating, investing, and financing cash movements

Cardinal Health generated $5.0B in operating cash flow over the trailing twelve months. After $617.0M in capital expenditures, free cash flow was $4.4B. Free cash flow increased 0.8% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating$1.5BNet Cash From Investing-$1.6BNet Cash From Financing$663.0MCapital Expenditures$232.0MDepreciation And Amortization Cf (TTM)$975.0MNet Change In Cash$719.0M
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$51.8B
P/E Ratio33.31
ROE37.39%

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired———$41M$1.4B—
Capital expenditures$193M——$108M$232M—
Proceeds from short-term investment in time deposit$350M——$200M——
Proceeds from disposals of property, plant and equipment$2M—————
Net cash from investing activities———-$142M-$1.6B—

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in accounts payable———$2.1B$1.8B—
Change in inventories-$2.4B——$736M$607M—
Other working capital changes———$699M$79M—
Change in receivables$773M——$539M$466M—
Deferred income taxes-$26M$60.8M$60.8M$60.8M$60.8M—
Depreciation and amortization$192M$207M$260M$233M$234M$248M
Net cash from operating activities$2.1B——$973M$1.5B—
Net income$401M$508M$417M$454M$471M$380M
Impairments and loss on sale of other investments-$2M———-$1M—
Gain (Loss) on Sale of Assets and Asset Impairment Charges-$3M$17M-$47M-$2M$14M-$185M
Accounts Receivable, Credit Loss Expense (Reversal)$8M——$13M$12M—
Repurchases of liability-classified units———-$22M——
Stock-based compensation$33M——$93M$153M—

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Repayments of debt$760M——$512M$11M—
Dividends paid$122M——$129M$120M—
Net tax withholding from share-based compensation$23M——-$80M-$1M—
Payments to Noncontrolling Interests-$4M——$3M$5M—
Proceeds from issuances of debt———$1.9B——
Net cash from financing activities-$859M——-$110M$663M—
Repurchases of common stock———$375M——

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$1.9B——$865M$1.3B—

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$2M——-$2M-$4M—
Net increase (decrease) in cash$1.4B——$719M——
Increase (decrease) in other investing items, net$15M——$7M$4M—
Proceeds from investments$250K—————

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Interest paid$53.5M$78.8M$78.8M$78.8M$78.8M—
Income Taxes Paid, Net$47.8M$111M$111M$111M$111M—